(Q36961269)

17 August 2017

Characteristics associated with important clinical end points in patients with chronic lymphocytic leukemia at initial treatment (English)

1 reference

chronic lymphocytic leukemia

17 August 2017

0 references

1 reference

1 reference

Hagop Kantarjian

1 reference

17 August 2017

Alessandra Ferrajoli

1 reference

17 August 2017

Stefan Faderl

1 reference

17 August 2017

William G Wierda

1 reference

17 August 2017

Jorge Cortes

1 reference

17 August 2017

Susan O'Brien

1 reference

17 August 2017

Guillermo Garcia-Manero

object named as

Guillermo Garcia-Manero

1 reference

17 August 2017

Michael Keating

1 reference

17 August 2017

Susan Lerner

1 reference

17 August 2017

Jan Burger

1 reference

17 August 2017

Xuemei Wang

1 reference

17 August 2017

Kim-Anh Do

1 reference

17 August 2017

Deborah Thomas

1 reference

17 August 2017

Charles Koller

1 reference

17 August 2017

language of work or name

English

0 references

publication date

17 February 2009

1 reference

Journal of Clinical Oncology

17 August 2017

1 reference

17 August 2017

1 reference

17 August 2017

1 reference

17 August 2017

1637-1643

1 reference

Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890649

Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890649

Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890649

Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890649

Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890649

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890649

Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890649

Prognosis of chronic lymphocytic leukemia: a multivariate regression analysis of 325 untreated patients.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890649

Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890649

Fludarabine and mitoxantrone for patients with chronic lymphocytic leukemia

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890649

A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890649

Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy

4 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19224852

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1200/JCO.2008.18.1701

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

19224852

1 reference